These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 27556823)
1. Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification. Brunelli M; Erdini F; Cima L; Eccher A; Fioravanzo A; Gobbo S; Segala D; Ghimenton C; Mazzoleni G; Munari E; Carella R; Martignoni G Appl Immunohistochem Mol Morphol; 2018; 26(5):316-323. PubMed ID: 27556823 [TBL] [Abstract][Full Text] [Related]
2. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers]. Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Pan CC; Chen PC; Ho DM Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648 [TBL] [Abstract][Full Text] [Related]
4. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma. Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273 [TBL] [Abstract][Full Text] [Related]
5. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling. Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590 [TBL] [Abstract][Full Text] [Related]
6. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma. Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941 [TBL] [Abstract][Full Text] [Related]
7. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas. Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901 [TBL] [Abstract][Full Text] [Related]
8. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290 [TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical significance of kidney injury molecule-1 in renal epithelial neoplasms]. Dong YC; Wu B; Wang JD; Rao Q; Ma HH; Zhang RS; Zhou HB; Lu ZF; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):35-9. PubMed ID: 20388397 [TBL] [Abstract][Full Text] [Related]
11. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Avery AK; Beckstead J; Renshaw AA; Corless CL Am J Surg Pathol; 2000 Feb; 24(2):203-10. PubMed ID: 10680888 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic approach to eosinophilic renal neoplasms. Kryvenko ON; Jorda M; Argani P; Epstein JI Arch Pathol Lab Med; 2014 Nov; 138(11):1531-41. PubMed ID: 25357116 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643 [TBL] [Abstract][Full Text] [Related]
14. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma. Wang HY; Mills SE Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088 [TBL] [Abstract][Full Text] [Related]
15. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570 [TBL] [Abstract][Full Text] [Related]
16. Different DNA ploidy patterns for the differentiation of common subtypes of renal tumors. Li G; Cottier M; Sabido O; Gentil-Perret A; Lambert C; Genin C; Tostain J Cell Oncol; 2005; 27(1):51-6. PubMed ID: 15750207 [TBL] [Abstract][Full Text] [Related]
17. Paxillin: application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma. Kuroda N; Guo L; Toi M; Naruse K; Miyazaki E; Hayashi Y; Yoshikawa C; Ashida S; Shuin T; Enzan H Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):315-8. PubMed ID: 11759057 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features. Alshenawy HA Pathol Oncol Res; 2015 Sep; 21(4):893-9. PubMed ID: 25712789 [TBL] [Abstract][Full Text] [Related]
19. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison. Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047 [TBL] [Abstract][Full Text] [Related]
20. Expression of the Na+/K+-transporting ATPase gamma subunit FXYD2 in renal tumors. Gaut JP; Crimmins DL; Lockwood CM; McQuillan JJ; Ladenson JH Mod Pathol; 2013 May; 26(5):716-24. PubMed ID: 23196795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]